Literature DB >> 22688064

Bypass surgery for moyamoya disease: concept and essence of sugical techniques.

Satoshi Kuroda1, Kiyohiro Houkin.   

Abstract

This review describes the basic concepts of surgical revascularization for moyamoya disease, including direct and indirect bypass surgery. Direct bypass surgery can improve cerebral hemodynamics and reduce further ischemic events immediately after surgery, but may be technically challenging in some pediatric patients. Indirect bypass surgery is simple and has widely been used. However, its beneficial effects can be achieved 3 to 4 months after surgery, and surgical design is quite important to determine the extent of surgical collateral pathways. Combined bypass procedure, especially superficial temporal artery (STA) to middle cerebral artery anastomosis and indirect bypass, encephalo-duro-myo-arterio-pericranial synangiosis, is a safe and effective option to improve the short- and long-term outcome in patients with moyamoya disease. Alternative techniques are also described for specific cases with profound cerebral ischemia in the anterior cerebral artery or posterior cerebral artery territory. Special techniques to safely complete bypass surgery and avoid perioperative complications are presented, including methods to prevent delayed wound healing, to avoid facial nerve palsy after surgery, and to preserve the STA and middle meningeal artery during skin incision and craniotomy. Finally, the importance of careful management of patients is emphasized to reduce the incidence of perioperative complications, including ischemic stroke and hyperperfusion syndrome.

Entities:  

Mesh:

Year:  2012        PMID: 22688064     DOI: 10.2176/nmc.52.287

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  12 in total

1.  Headache attack followed by rapid disease progression in pediatric moyamoya disease--how should we manage it?

Authors:  Sandra Vuignier; Naoki Akioka; Hideo Hamada; Daina Kashiwazaki; Satoshi Kuroda
Journal:  Childs Nerv Syst       Date:  2014-04-01       Impact factor: 1.475

2.  Assessment of the cortical artery using computed tomography angiography for bypass surgery in moyamoya disease.

Authors:  Hime Suzuki; Takeshi Mikami; Katsuya Komatsu; Shouhei Noshiro; Kei Miyata; Toru Hirano; Masahiko Wanibuchi; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2016-07-30       Impact factor: 3.042

3.  Diagnosis and Management of Moyamoya Disease.

Authors:  Shinichiro Uchiyama; Masako Yamazaki; Tatsuya Ishikawa; Koji Yamaguchi; Takakazu Kawamata
Journal:  Case Rep Neurol       Date:  2020-12-14

4.  Venous reddening as a possible sign of hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: case report.

Authors:  Toshio Machida; Junichi Ono; Ryota Nomura; Atsushi Fujikawa; Osamu Nagano; Yoshinori Higuchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-03-27       Impact factor: 1.742

Review 5.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

Review 6.  Progress on Complications of Direct Bypass for Moyamoya Disease.

Authors:  Jinlu Yu; Lei Shi; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

Review 7.  Clinical importance of the middle meningeal artery: A review of the literature.

Authors:  Jinlu Yu; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-10-17       Impact factor: 3.738

8.  Effect of intraoperative infusion of dexmedetomidine on postoperative recovery in patients undergoing endovascular interventional therapies: A prospective, randomized, controlled trial.

Authors:  Chunguang Ren; Huiying Xu; Guangjun Xu; Lei Liu; Guoying Liu; Zongwang Zhang; Jun-Li Cao
Journal:  Brain Behav       Date:  2019-05-17       Impact factor: 2.708

9.  Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.

Authors:  Jin He; Rong Wang; Dong Zhang; Yan Zhang; Qian Zhang; Jizong Zhao
Journal:  Exp Ther Med       Date:  2014-05-14       Impact factor: 2.447

10.  The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease: A Meta-Analysis.

Authors:  Cong Qian; Xiaobo Yu; Jianru Li; Jingyin Chen; Lin Wang; Gao Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.